Ambrx to be Added to the NASDAQ Biotechnology Index
Ambrx Biopharma, Inc., or Ambrx, (NASDAQ: AMAM), today announced that the Company will be added to the NASDAQ Biotechnology Index (NASDAQ: NBI), effective prior to the market open on Monday, December 18, 2023.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.